Listed

Petmed Express Inc

PETSNasdaqCIK 1040130Consumer staplesFiscal year ends Mar 31

Latest reported revenue, Q1 FY2027$41.0mRevenue, Q1 FY2027, three months to 2026-06-30$41.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001040130-26-000041.Report this figureThree months to Jun 30, 2026, from the 10-Q filed Aug 13, 2026.

Latest quarter: Q1 FY2027

Three months to Jun 30, 2026, against the same quarter a year earlier.

  • Revenue$41.0mRevenue, Q1 FY2027, three months to 2026-06-30$41.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001040130-26-000041.Report this figure−19.9% on a year earlier
  • Gross margin27.6%Gross margin, Q1 FY2027, three months to 2026-06-30. gross profit / revenueGross profit: $11.3m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-13, accession 0001040130-26-000041.Revenue: $41.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001040130-26-000041.Report this figure−0.5 pts on a year earlier
  • Operating margin−15.2%Operating margin, Q1 FY2027, three months to 2026-06-30. operating income / revenueOperating income: −$6.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001040130-26-000041.Revenue: $41.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001040130-26-000041.Report this figure+51.5 pts on a year earlier
  • Net margin−15.0%Net margin, Q1 FY2027, three months to 2026-06-30. net income / revenueNet income: −$6.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001040130-26-000041.Revenue: $41.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001040130-26-000041.Report this figure+51.7 pts on a year earlier
  • Diluted EPS−$0.28Diluted EPS, Q1 FY2027, three months to 2026-06-30−$0.28 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001040130-26-000041.Report this figure+83.0% on a year earlier
  • Free cash flow−$8.3mFree cash flow, Q1 FY2027, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: −$7.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001040130-26-000041.Capital expenditure: $641.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-13, accession 0001040130-26-000041.Report this figure+38.6% on a year earlier

Last eight quarters

Full statements
Revenue$41.0mGross margin 27.6%
Diluted EPS−$0.28, Q1 FY2027
Free cash flow−$8.3m, Q1 FY2027
Petmed Express Inc, key figures for the last eight quarters
Line itemUnitQ2 FY20252024-09-30Q3 FY20252024-12-31Q4 FY20252025-03-31Q1 FY20262025-06-30Q2 FY20262025-09-30Q3 FY20262025-12-31Q4 FY20262026-03-31Q1 FY20272026-06-30Shape over the periods
Revenue$m58.0Revenue, Q2 FY2025, three months to 2024-09-30$58.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-12-19, accession 0001040130-25-000108.Report this figure52.0Revenue, Q3 FY2025, three months to 2024-12-31$52.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-02-05, accession 0001040130-26-000007.Report this figure50.8Revenue, Q4 FY2025, three months to 2025-03-31$50.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-06-02, accession 0001040130-26-000019. Derived: 12-month figure less the 9-month figure.Report this figure51.2Revenue, Q1 FY2026, three months to 2025-06-30$51.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001040130-26-000041.Report this figure44.4Revenue, Q2 FY2026, three months to 2025-09-30$44.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-12-19, accession 0001040130-25-000108.Report this figure40.7Revenue, Q3 FY2026, three months to 2025-12-31$40.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-02-05, accession 0001040130-26-000007.Report this figure42.8Revenue, Q4 FY2026, three months to 2026-03-31$42.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-06-02, accession 0001040130-26-000019. Derived: 12-month figure less the 9-month figure.Report this figure41.0Revenue, Q1 FY2027, three months to 2026-06-30$41.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001040130-26-000041.Report this figure
Gross margin%32.3%Gross margin, Q2 FY2025, three months to 2024-09-30. gross profit / revenueGross profit: $18.8m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-12-19, accession 0001040130-25-000108.Revenue: $58.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-12-19, accession 0001040130-25-000108.Report this figure31.0%Gross margin, Q3 FY2025, three months to 2024-12-31. gross profit / revenueGross profit: $16.1m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-02-05, accession 0001040130-26-000007.Revenue: $52.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-02-05, accession 0001040130-26-000007.Report this figure29.9%Gross margin, Q4 FY2025, three months to 2025-03-31. gross profit / revenueGross profit: $15.2m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-06-02, accession 0001040130-26-000019. Derived: 12-month figure less the 9-month figure.Revenue: $50.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-06-02, accession 0001040130-26-000019. Derived: 12-month figure less the 9-month figure.Report this figure28.1%Gross margin, Q1 FY2026, three months to 2025-06-30. gross profit / revenueGross profit: $14.4m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-13, accession 0001040130-26-000041.Revenue: $51.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001040130-26-000041.Report this figure28.0%Gross margin, Q2 FY2026, three months to 2025-09-30. gross profit / revenueGross profit: $12.4m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-12-19, accession 0001040130-25-000108.Revenue: $44.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-12-19, accession 0001040130-25-000108.Report this figure23.3%Gross margin, Q3 FY2026, three months to 2025-12-31. gross profit / revenueGross profit: $9.5m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-02-05, accession 0001040130-26-000007.Revenue: $40.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-02-05, accession 0001040130-26-000007.Report this figure32.6%Gross margin, Q4 FY2026, three months to 2026-03-31. gross profit / revenueGross profit: $13.9m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-06-02, accession 0001040130-26-000019. Derived: 12-month figure less the 9-month figure.Revenue: $42.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-06-02, accession 0001040130-26-000019. Derived: 12-month figure less the 9-month figure.Report this figure27.6%Gross margin, Q1 FY2027, three months to 2026-06-30. gross profit / revenueGross profit: $11.3m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-13, accession 0001040130-26-000041.Revenue: $41.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001040130-26-000041.Report this figure
Operating margin%1.0%Operating margin, Q2 FY2025, three months to 2024-09-30. operating income / revenueOperating income: $554.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-12-19, accession 0001040130-25-000108.Revenue: $58.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-12-19, accession 0001040130-25-000108.Report this figure(0.9%)Operating margin, Q3 FY2025, three months to 2024-12-31. operating income / revenueOperating income: −$450.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-02-05, accession 0001040130-26-000007.Revenue: $52.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-02-05, accession 0001040130-26-000007.Report this figure(11.9%)Operating margin, Q4 FY2025, three months to 2025-03-31. operating income / revenueOperating income: −$6.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-06-02, accession 0001040130-26-000019. Derived: 12-month figure less the 9-month figure.Revenue: $50.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-06-02, accession 0001040130-26-000019. Derived: 12-month figure less the 9-month figure.Report this figure(66.7%)Operating margin, Q1 FY2026, three months to 2025-06-30. operating income / revenueOperating income: −$34.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001040130-26-000041.Revenue: $51.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001040130-26-000041.Report this figure(18.9%)Operating margin, Q2 FY2026, three months to 2025-09-30. operating income / revenueOperating income: −$8.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-12-19, accession 0001040130-25-000108.Revenue: $44.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-12-19, accession 0001040130-25-000108.Report this figure(25.7%)Operating margin, Q3 FY2026, three months to 2025-12-31. operating income / revenueOperating income: −$10.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-02-05, accession 0001040130-26-000007.Revenue: $40.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-02-05, accession 0001040130-26-000007.Report this figure(13.3%)Operating margin, Q4 FY2026, three months to 2026-03-31. operating income / revenueOperating income: −$5.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-06-02, accession 0001040130-26-000019. Derived: 12-month figure less the 9-month figure.Revenue: $42.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-06-02, accession 0001040130-26-000019. Derived: 12-month figure less the 9-month figure.Report this figure(15.2%)Operating margin, Q1 FY2027, three months to 2026-06-30. operating income / revenueOperating income: −$6.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001040130-26-000041.Revenue: $41.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001040130-26-000041.Report this figure
Net margin%4.0%Net margin, Q2 FY2025, three months to 2024-09-30. net income / revenueNet income: $2.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-12-19, accession 0001040130-25-000108.Revenue: $58.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-12-19, accession 0001040130-25-000108.Report this figure(1.4%)Net margin, Q3 FY2025, three months to 2024-12-31. net income / revenueNet income: −$707.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-02-05, accession 0001040130-26-000007.Revenue: $52.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-02-05, accession 0001040130-26-000007.Report this figure(22.9%)Net margin, Q4 FY2025, three months to 2025-03-31. net income / revenueNet income: −$11.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-06-02, accession 0001040130-26-000019. Derived: 12-month figure less the 9-month figure.Revenue: $50.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-06-02, accession 0001040130-26-000019. Derived: 12-month figure less the 9-month figure.Report this figure(66.7%)Net margin, Q1 FY2026, three months to 2025-06-30. net income / revenueNet income: −$34.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001040130-26-000041.Revenue: $51.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001040130-26-000041.Report this figure(19.2%)Net margin, Q2 FY2026, three months to 2025-09-30. net income / revenueNet income: −$8.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-12-19, accession 0001040130-25-000108.Revenue: $44.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-12-19, accession 0001040130-25-000108.Report this figure(26.0%)Net margin, Q3 FY2026, three months to 2025-12-31. net income / revenueNet income: −$10.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-02-05, accession 0001040130-26-000007.Revenue: $40.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-02-05, accession 0001040130-26-000007.Report this figure(9.5%)Net margin, Q4 FY2026, three months to 2026-03-31. net income / revenueNet income: −$4.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-06-02, accession 0001040130-26-000019. Derived: 12-month figure less the 9-month figure.Revenue: $42.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-06-02, accession 0001040130-26-000019. Derived: 12-month figure less the 9-month figure.Report this figure(15.0%)Net margin, Q1 FY2027, three months to 2026-06-30. net income / revenueNet income: −$6.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001040130-26-000041.Revenue: $41.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001040130-26-000041.Report this figure
Diluted EPS$ per share0.11Diluted EPS, Q2 FY2025, three months to 2024-09-30$0.11 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-12-19, accession 0001040130-25-000108.Report this figure(0.03)Diluted EPS, Q3 FY2025, three months to 2024-12-31−$0.03 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-02-05, accession 0001040130-26-000007.Report this figurenot reported (Diluted EPS not reported)(1.65)Diluted EPS, Q1 FY2026, three months to 2025-06-30−$1.65 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001040130-26-000041.Report this figure(0.41)Diluted EPS, Q2 FY2026, three months to 2025-09-30−$0.41 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-12-19, accession 0001040130-25-000108.Report this figure(0.50)Diluted EPS, Q3 FY2026, three months to 2025-12-31−$0.50 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-02-05, accession 0001040130-26-000007.Report this figurenot reported (Diluted EPS not reported)(0.28)Diluted EPS, Q1 FY2027, three months to 2026-06-30−$0.28 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001040130-26-000041.Report this figure
Free cash flow$m6.1Free cash flow, Q2 FY2025, three months to 2024-09-30. operating cash flow − capital expenditureOperating cash flow: $7.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-12-19, accession 0001040130-25-000108. Derived: 6-month figure less the 3-month figure.Capital expenditure: $1.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-12-19, accession 0001040130-25-000108. Derived: 6-month figure less the 3-month figure.Report this figure(1.9)Free cash flow, Q3 FY2025, three months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: −$1.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-02-05, accession 0001040130-26-000007. Derived: 9-month figure less the 6-month figure.Capital expenditure: $777.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-02-05, accession 0001040130-26-000007. Derived: 9-month figure less the 6-month figure.Report this figure4.6Free cash flow, Q4 FY2025, three months to 2025-03-31. operating cash flow − capital expenditureOperating cash flow: $7.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-06-02, accession 0001040130-26-000019. Derived: 12-month figure less the 9-month figure.Capital expenditure: $2.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-06-02, accession 0001040130-26-000019. Derived: 12-month figure less the 9-month figure.Report this figure(13.6)Free cash flow, Q1 FY2026, three months to 2025-06-30. operating cash flow − capital expenditureOperating cash flow: −$12.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001040130-26-000041.Capital expenditure: $1.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-13, accession 0001040130-26-000041.Report this figure(4.8)Free cash flow, Q2 FY2026, three months to 2025-09-30. operating cash flow − capital expenditureOperating cash flow: −$2.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-12-19, accession 0001040130-25-000108. Derived: 6-month figure less the 3-month figure.Capital expenditure: $2.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-12-19, accession 0001040130-25-000108. Derived: 6-month figure less the 3-month figure.Report this figure(9.2)Free cash flow, Q3 FY2026, three months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: −$9.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-02-05, accession 0001040130-26-000007. Derived: 9-month figure less the 6-month figure.Capital expenditure: −$21.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-02-05, accession 0001040130-26-000007. Derived: 9-month figure less the 6-month figure.Report this figure(5.5)Free cash flow, Q4 FY2026, three months to 2026-03-31. operating cash flow − capital expenditureOperating cash flow: −$4.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-06-02, accession 0001040130-26-000019. Derived: 12-month figure less the 9-month figure.Capital expenditure: $720.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-06-02, accession 0001040130-26-000019. Derived: 12-month figure less the 9-month figure.Report this figure(8.3)Free cash flow, Q1 FY2027, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: −$7.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001040130-26-000041.Capital expenditure: $641.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-13, accession 0001040130-26-000041.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Last five fiscal years

Revenue$179.0mGross margin 28.1%
Diluted EPS−$2.74, FY2026
Free cash flow−$33.0m, FY2026
Petmed Express Inc, key figures for the last five fiscal years
Line itemUnitFY20222022-03-31FY20232023-03-31FY20242024-03-31FY20252025-03-31FY20262026-03-31Shape over the periods
Revenue$m272Revenue, FY2022, twelve months to 2022-03-31$272.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2024-06-14, accession 0001040130-24-000046.Report this figure248Revenue, FY2023, twelve months to 2023-03-31$247.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-10-14, accession 0001040130-25-000072.Report this figure274Revenue, FY2024, twelve months to 2024-03-31$274.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-06-02, accession 0001040130-26-000019.Report this figure227Revenue, FY2025, twelve months to 2025-03-31$227.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-06-02, accession 0001040130-26-000019.Report this figure179Revenue, FY2026, twelve months to 2026-03-31$179.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-06-02, accession 0001040130-26-000019.Report this figure
Gross margin%28.3%Gross margin, FY2022, twelve months to 2022-03-31. gross profit / revenueGross profit: $76.9m. XBRL concept us-gaap:GrossProfit. 10-K filed 2024-06-14, accession 0001040130-24-000046.Revenue: $272.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2024-06-14, accession 0001040130-24-000046.Report this figure30.9%Gross margin, FY2023, twelve months to 2023-03-31. gross profit / revenueGross profit: $76.5m. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-10-14, accession 0001040130-25-000072.Revenue: $247.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-10-14, accession 0001040130-25-000072.Report this figure30.9%Gross margin, FY2024, twelve months to 2024-03-31. gross profit / revenueGross profit: $84.8m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-06-02, accession 0001040130-26-000019.Revenue: $274.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-06-02, accession 0001040130-26-000019.Report this figure30.5%Gross margin, FY2025, twelve months to 2025-03-31. gross profit / revenueGross profit: $69.1m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-06-02, accession 0001040130-26-000019.Revenue: $227.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-06-02, accession 0001040130-26-000019.Report this figure28.1%Gross margin, FY2026, twelve months to 2026-03-31. gross profit / revenueGross profit: $50.2m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-06-02, accession 0001040130-26-000019.Revenue: $179.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-06-02, accession 0001040130-26-000019.Report this figure
Operating margin%8.9%Operating margin, FY2022, twelve months to 2022-03-31. operating income / revenueOperating income: $24.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2024-06-14, accession 0001040130-24-000046.Revenue: $272.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2024-06-14, accession 0001040130-24-000046.Report this figure2.4%Operating margin, FY2023, twelve months to 2023-03-31. operating income / revenueOperating income: $6.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-10-14, accession 0001040130-25-000072.Revenue: $247.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-10-14, accession 0001040130-25-000072.Report this figure(3.0%)Operating margin, FY2024, twelve months to 2024-03-31. operating income / revenueOperating income: −$8.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-06-02, accession 0001040130-26-000019.Revenue: $274.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-06-02, accession 0001040130-26-000019.Report this figure(0.7%)Operating margin, FY2025, twelve months to 2025-03-31. operating income / revenueOperating income: −$1.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-06-02, accession 0001040130-26-000019.Revenue: $227.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-06-02, accession 0001040130-26-000019.Report this figure(32.8%)Operating margin, FY2026, twelve months to 2026-03-31. operating income / revenueOperating income: −$58.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-06-02, accession 0001040130-26-000019.Revenue: $179.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-06-02, accession 0001040130-26-000019.Report this figure
Net margin%6.9%Net margin, FY2022, twelve months to 2022-03-31. net income / revenueNet income: $18.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2024-06-14, accession 0001040130-24-000046.Revenue: $272.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2024-06-14, accession 0001040130-24-000046.Report this figure2.1%Net margin, FY2023, twelve months to 2023-03-31. net income / revenueNet income: $5.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-10-14, accession 0001040130-25-000072.Revenue: $247.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-10-14, accession 0001040130-25-000072.Report this figure(2.7%)Net margin, FY2024, twelve months to 2024-03-31. net income / revenueNet income: −$7.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-06-02, accession 0001040130-26-000019.Revenue: $274.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-06-02, accession 0001040130-26-000019.Report this figure(2.8%)Net margin, FY2025, twelve months to 2025-03-31. net income / revenueNet income: −$6.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-06-02, accession 0001040130-26-000019.Revenue: $227.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-06-02, accession 0001040130-26-000019.Report this figure(32.0%)Net margin, FY2026, twelve months to 2026-03-31. net income / revenueNet income: −$57.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-06-02, accession 0001040130-26-000019.Revenue: $179.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-06-02, accession 0001040130-26-000019.Report this figure
Diluted EPS$ per share0.92Diluted EPS, FY2022, twelve months to 2022-03-31$0.92 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2024-06-14, accession 0001040130-24-000046.Report this figure0.25Diluted EPS, FY2023, twelve months to 2023-03-31$0.25 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2025-10-14, accession 0001040130-25-000072.Report this figure(0.37)Diluted EPS, FY2024, twelve months to 2024-03-31−$0.37 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-06-02, accession 0001040130-26-000019.Report this figure(0.30)Diluted EPS, FY2025, twelve months to 2025-03-31−$0.30 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-06-02, accession 0001040130-26-000019.Report this figure(2.74)Diluted EPS, FY2026, twelve months to 2026-03-31−$2.74 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-06-02, accession 0001040130-26-000019.Report this figure
Free cash flow$m16.7Free cash flow, FY2022, twelve months to 2022-03-31. operating cash flow − capital expenditureOperating cash flow: $18.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2024-06-14, accession 0001040130-24-000046.Capital expenditure: $1.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2024-06-14, accession 0001040130-24-000046.Report this figure22.5Free cash flow, FY2023, twelve months to 2023-03-31. operating cash flow − capital expenditureOperating cash flow: $27.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-10-14, accession 0001040130-25-000072.Capital expenditure: $5.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-10-14, accession 0001040130-25-000072.Report this figure(0.2)Free cash flow, FY2024, twelve months to 2024-03-31. operating cash flow − capital expenditureOperating cash flow: $4.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-06-02, accession 0001040130-26-000019.Capital expenditure: $4.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-06-02, accession 0001040130-26-000019.Report this figure(0.4)Free cash flow, FY2025, twelve months to 2025-03-31. operating cash flow − capital expenditureOperating cash flow: $4.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-06-02, accession 0001040130-26-000019.Capital expenditure: $5.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-06-02, accession 0001040130-26-000019.Report this figure(33.0)Free cash flow, FY2026, twelve months to 2026-03-31. operating cash flow − capital expenditureOperating cash flow: −$28.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-06-02, accession 0001040130-26-000019.Capital expenditure: $4.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-06-02, accession 0001040130-26-000019.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Insider purchases and sales

All insider transactions

The last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.

No open-market purchases or sales by insiders are in coverage from Nov 2024 to Oct 2026.

No open-market purchases or sales by insiders are in coverage for this company.

Funds that report holding it

All funds

From each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.

Funds that report holding Petmed Express Inc
FundQuarter endedReported valueSharesPut or callChange on the quarter before
RENAISSANCE TECHNOLOGIES LLC2026-06-30$2.2m1,131,230Reduced−55,139
VANGUARD CAPITAL MANAGEMENT LLC2026-06-30$1.6m827,397Reduced−4,034
BlackRock, Inc.2026-06-30$1.1m568,255Added+16,578
FEDERATED HERMES, INC.2026-06-30$407.4k212,170Reduced−454,635
GEODE CAPITAL MANAGEMENT, LLC2026-06-30$391.9k204,075Reduced−17,447
STEEL PARTNERS HOLDINGS L.P.2026-06-30$371.8k193,664Unchanged
UBS Group AG2026-06-30$265.6k138,330Reduced−95,346
BRIDGEWAY CAPITAL MANAGEMENT, LLC2026-06-30$232.4k121,048Reduced−11,676
Rangeley Capital, LLC2026-06-30$232.3k121,000Added+11,792
VANGUARD FIDUCIARY TRUST CO2026-06-30$212.1k110,481Added+769

Recent filings

All 836 filings

Reports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.

Petmed Express Inc, recent filings
FiledFormWhat it isAccession number
2026-09-2816:27 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001040130-26-000057
2026-09-2108:35 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001040130-26-000047
2026-09-1709:08 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001040130-26-000045
2026-08-1316:58 ET10-QQuarterly reportPeriod 2026-06-300001040130-26-000041
2026-08-1316:17 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001040130-26-000040
2026-08-1216:30 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001040130-26-000036
2026-07-2309:26 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001040130-26-000029
2026-06-2907:36 ETSCHEDULE 13D/AOwnership report, active investor, amended0001213900-26-072848
2026-06-2616:10 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001040130-26-000027
2026-06-2516:19 ETDEF 14AProxy statementPeriod 2026-08-110001040130-26-000023

Latest annual report

Form 10-K for the fiscal year ended Mar 31, 2026Filed Jun 2, 2026. Its page lists the documents and the extracted sections, such as Business and Risk factors.

Forecast league

Q2 FY2027, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by [object Promise].Forecast this quarter

About the filer

CIK
1040130
Tickers
PETS
Exchange
Nasdaq
SIC code
5912 Retail-Drug Stores and Proprietary Stores
Sector
Consumer staples
Fiscal year ends
Mar 31
Incorporated in
FL
Filer category
Non-accelerated filer<br>Smaller reporting company

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:31 ET. Listed shows no prices and gives no investment advice.